Showing posts with label Hematology. Show all posts
Showing posts with label Hematology. Show all posts

Sunday, May 9, 2010

Aplastic Crises In Sickle Cell Anemia

Because sickle cell anemia is a congenital hemolytic anemia, there is ongoing red cell destruction, which must be supported by endogenous erythropoiesis manifest as reticulocytosis. Any concurrent illness that suppresses endogenous erythropoiesis will result in reticulocytopenia and a decrease in hemoglobin level and hematocrit.

Acute aplastic crises are characterized by a decrease in the level of hemoglobin of >3.0 g per dL in the setting of reticulocytopenia.

Causes :
These crises often occur in association with an infection that leads to transient bone marrow suppression; human parvovirus B19, the etiologic agent of erythema infectiosum (fifth disease), is notorious for causing this complication.

Management:
Patients should be given supportive red cell transfusions when they have hemodynamic instability, which may present with tachycardia, tachypnea, postural hypotension, and unstable blood pressure. Symptomatic anemia, indicative of the need for transfusion, includes dyspnea, dizziness, excessive fatigue, and difficulty in concentrating. Clinical management depends on the degree of anemia and cardiovascular compromise. Aggressive transfusions should be avoided, because transfusion to levels much above the patient's baseline hematocrit may suppress endogenous erythropoiesis further

Acute Splenic Sequestration Crises In Sickle Cell Anemia

Acute splenic sequestration is the sudden pooling of blood in the spleen resulting in anemia, which may be life threatening. This type of crisis occurs most often in young children between 10 and 27 months of age in whom autoinfarction of the spleens has not yet happened.
The cause of this syndrome is unclear; it may be seen in the setting of concurrent bacterial or viral infection.

Diagnostic criteria
The diagnostic criteria for acute splenic sequestration include an acutely enlarging spleen, a decrease in hemoglobin level of at least 2 g per dL below baseline, thrombocytopenia often with a platelet count <100,000 per mm,3 leukopenia, and evidence of bone marrow compensation with reticulocytosis.

In its most severe form, acute splenic sequestration results in life-threatening anemia, hypovolemia, and shock. Decreases in the levels of hemoglobin <4 g per dL are associated with 35% mortality rates. It is estimated that as much as 50% of the patient's red cells can be sequestered in the spleen. Approximately 50% of patients who survive an episode of acute splenic sequestration will experience a recurrence.

Mangement
Emergency management is aimed at restoring circulatory blood volume and hemodynamic stability. Although

Saturday, May 8, 2010

Clinical Manifestations of Hereditary spherocytosis


Hereditary spherocytosis may be a cause of hemolytic disease in the newborn and may present as anemia and hyperbilirubinemia sufficiently severe to require phototherapy or exchange transfusions. Hemolysis may be more prominent in the newborn because hemoglobin F binds 2,3-diphosphoglycerate poorly, and the increased level of free 2,3-diphosphoglycerate destabilizes spectrin-actin-protein 4.1 interactions in the RBC membrane .

The severity of symptoms in infants and children is variable. Some children remain asymptomatic into adulthood, but others may have severe anemia, with pallor, jaundice, fatigue, and exercise intolerance. Severe cases may be marked by expansion of the diploƫ of the skull and the medullary region of other bones, but to a lesser extent than in thalassemia major.

 After infancy, the spleen is usually enlarged, and pigmentary (bilirubin) gallstones may form as early as age 4–5 yr. At least 50% of unsplenectomized patients ultimately form gallstones, although they may be asymptomatic. Because of the high RBC turnover and heightened erythroid marrow activity, children with hereditary spherocytosis are susceptible to aplastic crisis, primarily as a result of parvovirus infection, and to hypoplastic crises associated with various other infections .

The erythroid marrow failure may result rapidly in profound anemia (hematocrit <10%), high-output heart failure, hypoxia, cardiovascular collapse, and death. White blood cell and platelet counts may also fall .